Outpatient intracameral viscosurgical device reinflation for early hypotony after PreserFlo MicroShunt implantation: a case series
Abstract
Purpose: To describe a simple and reproducible stepwise outpatient management approach using intracameral high-viscosity ophthalmic viscosurgical device (OVD) reinflation for early Seidel-negative hypotony with shallow anterior chamber (AC) and choroidal detachment (CD) after PreserFlo MicroShunt implantation.
Observations: This retrospective case series included three consecutive pseudophakic glaucoma eyes that developed Seidel-negative hypotony (lowest intraocular pressure [IOP] 3-5 mmHg) with shallow AC and CD in the early postoperative period after PMS implantation (including one case after bleb revision). In all eyes, a fixed initial small volume (0.2 mL) of high-viscosity or viscoadaptive sodium hyaluronate was injected intracamerally at the slit lamp or under the operating microscope to restore AC depth and IOP. AC reformation and CD resolution were achieved within 1-4 days without additional surgical intervention. No clinically evident corneal endothelial decompensation, visually significant IOP spikes (≥20 mmHg), or loss of visual acuity occurred during follow-up.
Conclusions and importance: Small-volume intracameral OVD reinflation appears to provide a simple, reproducible, and minimally invasive first-line option for early Seidel-negative hypotony after PMS implantation. A stepwise outpatient management approach may help standardize clinical decision-making for PMS-related shallow AC and CD, potentially reducing the need for reoperation while maintaining IOP…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.